Health X Platform Ltd · NSE:HEALTHX
Health X Platform — SastaSundar Ventures — Investor Presentation (November 2017)
47 slides from Health X Platform's investor presentation, November 2017
Slide 1: Investor Presentation November 2017
INVESTOR PRESENTATION November 2017 SastaSundar.com (A Venture of SastaSundar Ventures Limited) Sastasundar.com is a subsidiary of 1 SastaSundar Ventures Limited
Slide 2: Opportunity – Country & Sector (1/2)
OPPORTUNITY – COUNTRY & SECTOR (1/2) INDIAN MARKET POTENTIAL: Retail Pharmacy Diagnostic LAB FMCG 15 Billion USD 06 Billion USD 65 Billion USD Expected Growth Expected Growth Expected Growth 15% CAGR 20% CAGR 14% CAGR Market Share of Organized Players Market Share of Organized Players Market Share o
Slide 3: Opportunity – Country & Sector (2/2)
OPPORTUNITY – COUNTRY & SECTOR (2/2) Walgreens Boots Alliance Why are Walgreens & CVS not present in India? Market CAP – 72 billion USD Small size store CVS Pharmacy Store size of Walgreens is about 25,000 Sq.ft. in comparison to Market CAP – 72 billion USD that India pharmacy store has around 500 S
Slide 4: Company Overview
COMPANY OVERVIEW 4 4
Slide 5: SastaSundar: About Us
SASTASUNDAR : ABOUT US • “Sasta Sundar” is a famous Indian phrase which denotes consumer aspiration for “High Quality at Low Cost”. • We are building Digital Network of Healthcare managing efficient Pharma & Wellness products Supply Chain & connecting Doctors, Diagnostic Services, Healthcare Clinics
Slide 6: Company Snapshot (1/3)
COMPANY SNAPSHOT (1/3) H1FY18 Product Categories * Own • SastaSundar Ventures Limited (Previously known as Microsec Brands OTC Financial Services Ltd) is a NSE and BSE listed company. 10% 2% Prescribed • SastaSundar.com started its operations in September, 2013 with a Medicines mission to provide lo
Slide 7: Company Snapshot (2/3)
COMPANY SNAPSHOT (2/3) SASTASUNDAR AT A GLANCE An Online to Offline retailer for genuine Medicines and other high quality OTC & healthcare products All kind of Medicines 186 Healthbuddies including Chronic covering 22 districts of 93% Customer medicines with West Bengal around 5.21 Retention Ratio.
Slide 8: Company Snapshot (3/3)
COMPANY SNAPSHOT (3/3) Year wise growth GMV in GMV (INR Mn) (INR Million) Year wise growth in No. of Orders (in Lakhs) 1,530 16.86 849 8.79 881 9.05 902 10.62 274 681* 2.98 8.07* FY15 FY16 FY 2017 H1FY18 FY15 FY16 FY17 H1FY18 *H1FY17 numbers #Growth in comparison of H1FY17 Medicine orders constitute
Slide 9: Founders
FOUNDERS B L Mittal (Executive Chairman) Banwari Lal Mittal is a fellow member of the Institute of Chartered Accountants - India, the Institute of Company Secretaries - India and the Institute of Costs and Works Accountants - India. He has over two decades of experience in nurturing businesses. He s
Slide 10: Key Managerial Personnel
KEY MANAGERIAL PERSONNEL Dheer Singh - CTO Dheer is an alumnus of DIT Delhi (now NSIT) in Instrumentation and Control, is a qualified technocrat and seasoned professional. He has rich and successful track record of over 17 years, inclusive of over 7 years of on-site working and Direct (5 years) enga
Slide 11: Competitive Advantage
COMPETITIVE ADVANTAGE Country's 5 ''D'' Company's People Customer Advantage Advantage Advantage Advantage • Mission Oriented • Genuine Medicines & High Drugs Business Quality Healthcare Products • Brand SastaSundar.com • Low Cost • Household relationship ''Being Genuine'' • ‘Free Home Delivery' & Do
Slide 12: Business Overview
BUSINESS OVERVIEW 12 12
Slide 13: Business Overview
BUSINESS OVERVIEW The company is building a Digital Network of Healthcare managing efficient Pharma & Wellness products Supply Chain & connecting Doctors, Diagnostic Services, Healthcare Clinics and Health Information Services. The Network is designed for the following services: 1.Access to Genuine
Slide 14: Business Operation
BUSINESS OPERATION Operation Sequence Order Placement CUSTOMER ONE TIME REGISTRATION LOGIN REORDER PREVIOUS ORDER ORDER PLACED SELECT PRODUCTS Order Processing CITY PHARMA RE-VERIFICATION ORDER SORT / PACK GEN. MEMO SHIPMENT TO HB WAREHOUSE * Re-verification if needed Order Completion HEALTHBUDDY RE
Slide 15: Marketing Strategy
MARKETING STRATEGY APP & Website Counseling using Health information Healthbuddy Counseling Services"Know Health” Search Engine Health Camps Optimization Consumer Gaming Quiz - Digital Engagement is Offline Delivery Van Branding Feedback & connection Online the Key Newspaper Advertisement Social Med
Slide 16: Innovation Leads to Uniqueness
INNOVATION LEADS TO UNIQUENESS Healthbuddy A human face powered by Technology & Centralised inventory offer, services at low cost. Emotional connect & counseling ensures lowest cost of customer acquisition and high degree of repeat orders. Technology Edge •The Artificial intelligence based upon Dise
Slide 17: Distribution Network
DISTRIBUTION NETWORK SastaSundar In WEST BENGAL • Covering the state of West Bengal - 22 Districts. • Elevation Centre is located at Kolkata, having 186 healthbuddy centers located at every 3 km Covering 22 of radius. Districts of • Covering 5.21 Lakh households West Bengal with 186 healthbuddy • He
Slide 18: Superior Technological Edge
SUPERIOR TECHNOLOGICAL EDGE Health Condition Data and Analytics • The Artificial intelligence based upon Disease bare data made us capable to provide consumer centric Personal servicing. Input Output • A diabetic patient can see diabetic related information • Patient • Location wise Disease through
Slide 19: Efficient Inventory Management
EFFICIENT INVENTORY MANAGEMENT • Efficient and low cost inventory management to ensure higher Procurement profitability and low risk profile. at Elevation Healthbuddy • Since 90% sales of medicines are for chronic diseases, reorder Centre Process by delivers the every 15 days expected sale is done a
Slide 20: Vendor Selection and Procurement Process
VENDOR SELECTION AND PROCUREMENT PROCESS SastaSundar targets the Pharma Companies and their distributor for purchase of medicines Vendor Identification process for OTC products Chronic and Generic Business Information shared medicines Intelligence Team with vendor Identification Identifies Fast acqu
Slide 21: Customer Centric Approach
CUSTOMER CENTRIC APPROACH Value to Customers Accessibility Affordability Convenience Mobile app is available in Android, IOS and Windows. Structured Information about medication, Reorder reminder tools their effects and side effects Personalized customer interface, dashboard Single button reorder fa
Slide 22: Own Brands (1/2)
OWN BRANDS (1/2) • DNAVITA (Customized Health Supplement Made of Natural Ingredients): A customized and Made-to-Order health supplement that allows customers to assess their nutritional needs through the creation of DNAVITA Health Profile on a digital & interactive web & mobile based interface. DNAV
Slide 23: Own Brands (2/2)
OWN BRANDS (2/2) • HealthBuddy CARE: A varied range of products, starting from wellness to hygiene, from cleanliness to elderly care. The product range is hygienic and designed to simplify the essential requirements of day-to-day life while maintaining quality and comfort. • Stoptar: A boon for thos
Slide 24: SastaSundar: Making Difference to Society
SASTASUNDAR: MAKING DIFFERENCE TO SOCIETY Delivering Medicine in Water Logged Areas Free Health Checkup Camp Free Nutritional Camp Delivering Medicine in Water Logged Areas Free Health Checkup Camp Medicine Donation 24
Slide 25: Strategic Overview
STRATEGIC OVERVIEW 25 25
Slide 26: Vision 2024
VISION 2024 Industry leading analytics best positioned for Pan India delivery network with USD 1 Ready for doctors, Global Companies Pharma Scale and diagnostic billion sales and 15% EBIDTA with high leads Return on Investment & High Growth Platform to launch and distribute A portfolio of own digita
Slide 27: Future Growth Strategy
FUTURE GROWTH STRATEGY Meaning of the Green Lines The green color line Built Model indicates our approach to & Brand validate before we take next SastaSundar stage. in one state in Pharma & FMCG With approach of ‘Think Big product line Act Small ’ , we keep our eyes on High Growth with operational e
Slide 28: Strategic Agreement with Rohto Pharmaceuticals
STRATEGIC AGREEMENT WITH ROHTO PHARMACEUTICALS SastaSundar Healthbuddy Limited has executed a share subscription agreement with Rohto Pharmaceuticals Ltd. in May 2017. Rohto Pharmaceuticals has subscribed 13% of share capital on a fully diluted basis for an aggregate investment of $5Mn in the compan
Slide 29: Expanding Our Presence
EXPANDING OUR PRESENCE • After the successfully penetration in the state of West Bengal, the company has planned to expand its presence in Delhi. • The work in Delhi is going as per plan and the company is expecting to New Delhi launch the services in Delhi in Q4-FY17-18. Market overview of Delhi Ko
Slide 30: New Initiatives
NEW INITIATIVES Starting Diagnostic Services by setting up Central Lab in Kolkata supported with multiple Reference lab (Centres) under a separate 100% wholly owned Subsidiary – Genu Path Labs Ltd. This subsidiary will enable the Healthbuddy network to provide extension of service from pharmacy to p
Slide 31: New Initiatives - Diagnostic Services
NEW INITIATIVES - DIAGNOSTIC SERVICES • Starting Diagnostic Services in Q4FY-18 by setting up Central Lab in Kolkata supported with multiple Reference lab (Centres). • This would be done in a separate 100% owned subsidiary of the company – Genu Path Labs Ltd. • This subsidiary will enable the Health
Slide 32: New Initiatives - Retailershakti
NEW INTIATIVES - RETAILERSHAKTI • Retailer Shakti is a platform to empower neighbourhood retailers to be a part of an organised inventory, technology & finance system to provide competitive advantage to their customers in terms of wide range of products, price & experience. • It provides the widest
Slide 33: Revenue Matrix & Economic Assets
REVENUE MATRIX & ECONOMIC ASSETS Contribution from selling of third party medicines Brand SastaSundar Contribution from selling of third party wellness products Contribution from selling of our products under Aspiration brand Our Digital Economic Healthbuddy Connectivity Network Contribution from li
Slide 34: Building Scale to Increase Profitability
BUILDING SCALE TO INCREASE PROFITABILITY Volume based discounting Inflexion Point 1. Larger scale will gives SastaSundar significant advantage to negotiate bulk discounts with distributors thereby improving their profitability Revenue Provides Negotiation Edge Profits 1. Higher scale offers signific
Slide 35: Creating a Database of Health Condition and Analytics
CREATING A DATABASE OF HEALTH CONDITION AND ANALYTICS Know Health Health Information Services Connect Services Symptoms Doctors Checker Appointment Health Health Articles Tools Wellness Telemedicine Service (Consultation Provider via video) Medicine Info & Emergency Substitute Handling LAB Tests Hos
Slide 36: SastaSundar – Market Penetration Strategy
SASTASUNDAR – MARKET PENETRATION STRATEGY Entry Create a Efficient Guaranteed through trusted centralized Entry next-day Create HB network medicines – a brand with procurement deliveries into City critical and HB presence leads to and Customer base and best repeating and quality highest fill prices
Slide 37: SastaSundar – Target Market
SASTASUNDAR – TARGET MARKET Top 12 States SastaSundar is targeting Each warehouse can to capture 10% of the cater to 250 micro- Pharma market in each pharmacies region Delhi Rajasthan Uttar Pradesh Gujarat Madhya Pradesh West Bengal Maharashtra Telangana These 12 Target States Sastasundar is would h
Slide 38: Financial Overview
FINANCIAL OVERVIEW 38 38
Slide 39: Financial Performance H1FY18 (Standalone)
FINANCIAL PERFORMANCE H1FY18 (STANDALONE) H1FY18 FY17 FY16 Particulars (INR Mn) (Unaudited) (Audited) (Audited) Revenue * 0.29 9.77 22.15 Expenses 9.27 18.00 20.27 EBIDTA (8.98) (8.23) 1.88 Depreciation 1.04 2.74 3.39 Profit / (Loss) before tax & exceptional items Particulars(10.02) (INR Mn) (10.97)
Slide 40: Financial Performance H1FY18 (Consolidated)
FINANCIAL PERFORMANCE H1FY18 (CONSOLIDATED) H1FY18 FY17 FY16 Particulars (INR Mn) (Unaudited) (Audited) (Audited) Revenue* 756.85 1,370.25 889.92 Expenses 827.33 1,552.52 1,175.45 EBIDTA (70.48) (182.27) (285.53) Finance Cost 9.19 28.09 10.02 Depreciation Particulars (INR 29.13 Mn) 69.18 72.79 (Loss
Slide 41: Financial Performance H1FY18 (Segmental)
FINANCIAL PERFORMANCE H1FY18 (SEGMENTAL) H1FY18 FY17 FY16 Particulars (INR Mn) (Unaudited) (Audited) (Audited) Segment Revenue Financial Services 96.18 203.45 194.56 Digital Pharmacy and Healthcare Store (www.sastasundar.com) 645.99 1124.84 661.94 Other Segment* 0.01 0.51 5.89 Total 742.18 1,328.80
Slide 42: Income Statement of Subsidiary SastaSundar.com
INCOME STATEMENT OF SUBSIDIARY SASTASUNDAR.COM H1FY18 FY17 FY16 Particulars (INR Mn) (Unaudited) (Audited) (Audited) Total Revenue* 649.26 1,126.45 638.19 Total Expenses 751.51 1,351.14 837.60 EBITDA (102.25) (224.69) (199.41) Depreciation 15.46 40.91 41.22 Finance Cost 2.81 11.91 6.75 Profit/Loss B
Slide 43: Consolidated Balance Sheet
CONSOLIDATED BALANCE SHEET Sources of Funds (INR in Mn) H1FY18 FY17 FY16 Application of Funds (INR in Mn) H1FY18 FY17 FY16 Equity & Liabilities Assets Shareholder's Fund Fixed Assets 634.85 674.05 689.88 Share Capital 318.10 318.10 318.10 Goodwill on Consolidation 550.67 573.85 573.85 Reserves & Sur
Slide 44: Capital Market Data
CAPITAL MARKET DATA 200% Sastasundar Sensex Price Data (30th September, 2017) INR 150% Face Value 10 100% Market Price 81.0 50% 52 Week H/L (INR) 154.3/43.2 0% Market Cap (INR Mn) 2,577 -50% Equity Shares Outstanding (Mn) 31.81 1 Year Avg. trading Volume ('000) 44.35 Share Holding Pattern (30th Sept
Slide 45: The Great Business Can Only Be Built by Solving Any Problem
THE GREAT BUSINESS CAN ONLY BE BUILT BY SOLVING ANY PROBLEM AND IF WE NEED TO SOLVE THE PROBLEM, LET US SOLVE THE BIGGER PROBLEM 45
Slide 46: Thank You
Thank You 46 Health & Happiness
Slide 47: Disclaimer
DISCLAIMER Sastasundar.com This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sastasundar.com (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for an
SastaSundar Ventures — Investor Presentation (November 2017) on 6ix